Medtronic received information that during the implant of a transcatheter bioprosthetic valve, the valve was deployed in the correct aortic position.A mild leak was reported and a balloon aortic valvuloplasty (bav) was performed with a 25 mm edward's balloon.The balloon was delivered through one of the valve struts and caused the valve to move up.The balloon became lodged in the valve and could not be released.Several attempts were made to release the valve, however, was unsuccessful.The patient had open heart surgery to remove the valve and balloon and a surgical valve was implanted.No further adverse patient effects were reported.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|